-
·
Stage 4 Non-Hodgkin Lymphoma Patient Story: I Said Yes to Bispecific Antibodies
Meg L., Follicular Lymphoma, Stage 4 Symptoms: Lower back pain, general feeling of unwellness Treatments: Clinical trial (bispecific antibody and immunotherapy)
-
·
Demystifying Follicular Lymphoma: Latest Advances in Precision Medicine and Emerging Therapies
Demystifying Follicular Lymphoma: Latest Advances in Precision Medicine and Emerging Therapies Dr. Peter Martin, a leading lymphoma expert at Weill Cornell Medicine, Laurie Adami, follicular lymphoma patient and advocate, and Tiffany Drummond, cancer advocate and clinical researcher, discuss the latest advancements in follicular lymphoma treatment.
-
·
Understanding New Options for Non-Hodgkin Lymphoma
Accessing the Best Care for You or a Loved One: Understanding New Options for Non-Hodgkin Lymphoma Dr. Kulsum Bano, Dr. Nilanjan Ghosh, and Dr. Justin Favaro discuss the latest advances with 3-time DLBCL survivor and patient advocate Dr. Robyn Stacy-Humphries.
-
·
The Role of Bispecific Antibodies in the Treatment of Multiple Myeloma
The Role of Bispecific Antibodies in the Treatment of Multiple Myeloma Hematologist Alfred Garfall, MD, MS, from Penn Medicine discusses with multiple myeloma patient advocate Jack Aiello the advancement of immunotherapy for multiple myeloma, the difference between CAR T-cell therapy & bispecific antibodies, and the role of bispecifics in the myeloma toolkit of immunotherapies.
